# China NMPA Drug Inspection - Xinxiang Changle Pharmaceutical Co., Ltd. - Ribavirin Injection

Source: https://www.keypedia.com/records/china_drug_inspection/xinxiang-changle-pharmaceutical-co-ltd/8bba4491-fc7c-4c00-b51a-2db2f4340a36
Source feed: China

> China NMPA drug inspection for Xinxiang Changle Pharmaceutical Co., Ltd. published March 20, 2020. Drug: Ribavirin Injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Xinxiang Changle Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Ribavirin Injection
- Inspection Finding: qualified

Company: https://www.keypedia.com/companies/xinxiang-changle-pharmaceutical-co-ltd/59194b89-548e-44ae-9b1e-63649c66bbbf